Gainers
- Avenue Therapeutics ATXI shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3 million.
- CTI BioPharma CTIC stock rose 60.0% to $3.04. The market value of their outstanding shares is at $293.9 million.
- GBS GBS stock moved upwards by 55.89% to $0.72. The market value of their outstanding shares is at $10.6 million.
- Chembio Diagnostics CEMI stock rose 14.52% to $1.1. The company's market cap stands at $33.0 million.
- DarioHealth DRIO stock moved upwards by 12.32% to $8.2. The market value of their outstanding shares is at $135.9 million.
- Atea Pharmaceuticals AVIR stock rose 11.19% to $7.05. The market value of their outstanding shares is at $585.8 million. As per the press release, Q4 earnings came out yesterday.
Losers
- GoodRx Holdings GDRX shares decreased by 33.9% to $18.12 during Tuesday's pre-market session. The company's market cap stands at $7.2 billion. As per the press release, Q4 earnings came out yesterday.
- Semler Scientific SMLR shares fell 21.92% to $57.0. The market value of their outstanding shares is at $385.1 million. As per the news, the Q4 earnings report came out yesterday.
- RadNet RDNT stock fell 14.88% to $21.0. The company's market cap stands at $1.1 billion. As per the press release, Q4 earnings came out today.
- Heron Therapeutics HRTX stock declined by 14.65% to $6.06. The market value of their outstanding shares is at $617.7 million. As per the news, the Q4 earnings report came out yesterday.
- Cidara Therapeutics CDTX stock decreased by 13.02% to $0.61. The company's market cap stands at $40.6 million.
- China SXT Pharmaceuticals SXTC stock decreased by 12.44% to $0.19. The company's market cap stands at $5.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in